POTASSIUM CHLORIDE EXTENDED-RELEASE TABL

The Defense Logistics Agency awarded Cardinal Health, Inc. a firm-fixed-price delivery order under solicitation SPE2D926F7404 for one bottle of Potassium Chloride Extended-Release Tablets, identified by NSN 6505012578457, at a total contract price of $24.73. The award was issued on July 16, 2026, with delivery required by the same date under delivery order SPE2DX25D8022. The item is to be delivered FOB destination with the contractor responsible for all transportation costs and risks until receipt by the government at the designated delivery point, which is Electric Boat Corporation in North Stonington, Connecticut. Inspection and acceptance occur at the destination, and no variance in quantity is permitted—exact delivery of one bottle is required. Packaging must comply with traceable shipping methods, explicitly prohibiting parcel post, and all shipments must include the Transportation Control Number N271646190ZJ75 along with the NSN and applicable CAGE codes for the ordering and contracting activities. No additional options, line items, or escalation clauses are included. The contract lacks explicit FAR clauses, detailed inspection criteria, or technical specifications beyond the NSN and unit of issue, suggesting reliance on established pharmaceutical and DLA supply standards. Funding is tracked internally using the PR number 7017530513 and FC code 68, with RDD 999 indicating immediate delivery timing. No representation of socioeconomic status, subcontracting plans, or compliance certifications are documented in the award notice. The absence of named contracting personnel, formal invoicing systems, or evaluation factors indicates this is a streamlined, low-value procurement under a low-price technically acceptable approach, typical for standard medical supply acquisitions within the DoD logistics network.